Literature DB >> 1740437

Molecular cloning of the major cell surface heparan sulfate proteoglycan from rat liver.

A Pierce1, M Lyon, I N Hampson, G J Cowling, J T Gallagher.   

Abstract

We have used an antiserum raised against a purified heparan sulfate proteoglycan (HSPG) preparation isolated from rat liver to screen a lambda gt11 expression library and have obtained overlapping cDNA clones that contain the full-length coding sequence of an HSPG core protein capable of spanning the plasma membrane. The open reading frame of the rat cDNA encodes a protein of 211 amino acids. The predicted protein sequence (23 kDa) has a high degree of homology with the published partial sequence of the human lung fibroblast HSPG, fibroglycan. The deduced protein sequence contains a 24-amino acid transmembrane domain and a 33-amino acid cytoplasmic domain, both of which are identical with the corresponding regions of human fibroglycan and are highly homologous to the human, hamster, and mouse epithelial HSPG, syndecan. The putative ectodomain, which has 85% homology to fibroglycan, contains three possible glycosaminoglycan attachment sites that may be occupied by heparan sulfate chains. The major 49-kDa core protein in the liver HSPG preparation was found to be reactive to an antibody that specifically recognizes the cytoplasmic domain of fibroglycan. We have used the full-length cDNA clone to analyze the expression of this transmembrane core protein gene in whole tissues and several epithelial and fibroblastoid cell lines. It hybridizes to three mRNA species in all cell and tissue types examined, but in liver, isolated hepatocytes, and kidney, an additional 0.8-kilobase mRNA was detected. The three common messages arise from differential use of alternative polyadenylation sites, whereas the fourth tissue-restricted RNA species represents a related gene transcript. The rat equivalent of human fibroglycan therefore appears to be the major transmembrane proteoglycan in liver, and its widespread expression in many diverse tissues and cells suggests that it plays an important role in cellular interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740437

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Molecular characterization of chicken syndecan-2 proteoglycan.

Authors:  Ligong Chen; John R Couchman; Jacqueline Smith; Anne Woods
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

2.  Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates.

Authors:  Yunfang Wang; Hsin-Lei Yao; Cai-Bin Cui; Eliane Wauthier; Claire Barbier; Martin J Costello; Nicholas Moss; Mitsuo Yamauchi; Marnisa Sricholpech; David Gerber; Elizabeth G Loboa; Lola M Reid
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

3.  Phosphorylation of a membrane-intercalated proteoglycan, syndecan-2, expressed in a stroma-inducing clone from a mouse Lewis lung carcinoma.

Authors:  N Itano; K Oguri; Y Nagayasu; Y Kusano; H Nakanishi; G David; M Okayama
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

Review 4.  Alternative poly(A) site selection in complex transcription units: means to an end?

Authors:  G Edwalds-Gilbert; K L Veraldi; C Milcarek
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

5.  Binding of perlecan to transthyretin in vitro.

Authors:  S Smeland; S O Kolset; M Lyon; K R Norum; R Blomhoff
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

6.  Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1.

Authors:  J Reiland; V L Ott; C S Lebakken; C Yeaman; J McCarthy; A C Rapraeger
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

7.  The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Authors:  I V Fuki; K M Kuhn; I R Lomazov; V L Rothman; G P Tuszynski; R V Iozzo; T L Swenson; E A Fisher; K J Williams
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 8.  Molecular functions of syndecan-1 in disease.

Authors:  Yvonne Hui-Fang Teng; Rafael S Aquino; Pyong Woo Park
Journal:  Matrix Biol       Date:  2011-10-18       Impact factor: 11.583

Review 9.  Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules.

Authors:  M Salmivirta; M Jalkanen
Journal:  Experientia       Date:  1995-09-29

10.  Analysis of transport and targeting of syndecan-1: effect of cytoplasmic tail deletions.

Authors:  H M Miettinen; S N Edwards; M Jalkanen
Journal:  Mol Biol Cell       Date:  1994-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.